About Bacilligen

About company

Bacilligen, Inc. is an early stage R&D Company focused on manufacturing treatments and vaccines for the oncology and infectious disease markets. Founded in March 2006, Drs. David Hone and Steve Bende, who collectively have invested 40 years into research and vaccine design, became dedicated to advancing medical technology in developing innovative solutions for cancer and infectious diseases.